Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the Phase 2 ONC201 Patient Selection and other Neuroendocrine Tumors such as Desmoplastic Small Round Cell Tumor, Neuroblastoma, and Clear-Cell Carcinoma
Phase 2 ONC201 Neuroendocrine Desmoplastic Small Round Cell Tumor Neuroblastoma Clear-Cell Carcinoma
